Page 4 - Rowena Guevarra News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rowena guevarra. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rowena Guevarra Today - Breaking & Trending Today

PH's Virology Institute to rise in Tarlac soon – DOST – Manila Bulletin


Published May 25, 2021, 5:04 PM
DOST (Manila Bulletin file photo)
The Department of Science and Technology (DOST) said it is currently coordinating with other government agencies for the construction of the Virology Institute of the Philippines (VIP).
The Bases Conversion and Development Authority (BCDA) has “allotted five hectares of land in the New Clark Economic Zone in Capas, Tarlac, as the VIP site,” said DOST Undersecretary Rowena Guevarra on Tuesday, May 25.
Currently, both the DOST and BCDA are “finalizing the term sheet before signing the lease contract.” The DOST is also in talks with the Department of Public Works and Highways (DPWH) for the building’s design, said Guevarra. ....

City Of Tarlac , The Philippines , Maria Rosario Vergeire , Virology Institute Of The Philippines , Department Of Science , Rd Research , Department Of Health , Department Of Public , Department Of Budget , Development Authority , Manila Bulletin , Virology Institute , Bases Conversion , New Clark Economic Zone , Rowena Guevarra , Public Works , Undersecretary Maria Rosario Vergeire , நகரம் ஆஃப் டார்லாக் , தி பிலிப்பைன்ஸ் , வைராலஜி நிறுவனம் ஆஃப் தி பிலிப்பைன்ஸ் , துறை ஆஃப் அறிவியல் , ர்ட் ஆராய்ச்சி , துறை ஆஃப் ஆரோக்கியம் , துறை ஆஃப் பொது , துறை ஆஃப் பட்ஜெட் , வளர்ச்சி அதிகாரம் ,

WHO solidarity vaccine trials in PH may start in June – DOST official – Manila Bulletin


(Photo by Orlando Sierra / AFP / FILE PHOTO)
DOST Undersecretary Rowena Guevarra said the solidarity trials will be funded by the Philippine government through the DOST and the Department of Health (DOH).
“Ini-expect natin na mag-umpisa yung sa WHO solidarity vaccine trials mga by June (We expect the WHO solidarity vaccine trials to begin by June),” Guevarra said in a public briefing.
For the clinical trials, Guevarra explained that volunteers from areas with high rates of infections will be recruited. They will then undergo protocols approved by the Food and Drug Administration (FDA) and the country’s Ethics Review Board.
“Ang gusto nilang malaman ay yung safety at saka yung efficacy nitong ating mga iba’t-ibang brands ng bakuna (What they want to know is the safety and also the efficacy of various brands of vaccines),” she said. ....

Rowena Guevarra , Task Group On Vaccine Evaluation , Department Of Science , Department Of Health , World Health Organization , Drug Administration , Orlando Sierra , Ethics Review , Task Group , Vaccine Evaluation , Belgium Based Janssen , பணி குழு ஆன் தடுப்பூசி மதிப்பீடு , துறை ஆஃப் அறிவியல் , துறை ஆஃப் ஆரோக்கியம் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , ஆர்ல்யாஂடொ சியரா , நெறிமுறைகள் விமர்சனம் , பணி குழு , தடுப்பூசி மதிப்பீடு , பெல்ஜியம் அடிப்படையிலானது ஜான்சன் ,

No 'solid conclusion' on Ivermectin use for COVID-19 treatment – DOST official – Manila Bulletin


(Photo from Pixabay)
DOST Undersecretary Rowena Guevarra said there are currently more than 50 clinical trials worldwide for the use of Ivermectin as possible treatment against COVID-19.
“Ang problema natin, walang solid na conclusion, merong nagsasabi na okay siya, merong nagsasabi na hindi siya okay (Our problem is, there is no solid conclusion. Some say it is okay, some say it is not),” Guevarra said in a public briefing Tuesday, May 25.
In the Philippines, the Food and Drug Administration (FDA) has allowed the limited use of Ivermectin under the conditions of a compassionate special permit.
“Sabi ng Philippine COVID-19 Living Clinical Practice Guidelines na nagsusuri ng current evidence sa Pilipinas at sa buong mundo, hindi pa rin sapat ang datos para mai-rekomenda ang paggamit ng Ivermectin bilang gamot sa mga pasyente na may mild to moderate COVID-19 (The Philippine COVID-19 Living Clinical Practice Guidelines, which examines current evidence in the Phi ....

Rowena Guevarra , Department Of Science , Department Of Health , Drug Administration , Lloyd Laboratories Inc , Clinical Practice Guidelines , Lloyd Laboratories , துறை ஆஃப் அறிவியல் , துறை ஆஃப் ஆரோக்கியம் , மருத்துவ ப்ர்யாக்டீஸ் வழிகாட்டுதல்கள் , லாயிட் ஆய்வகங்கள் ,

DOST: Three other vaccine developers seek approval to conduct COVID-19 vaccine trial in PH


Published May 25, 2021, 2:14 PM
DOST (Manila Bulletin File photo)
Three other vaccine developers are interested in conducting a clinical trial in the Philippines for their respective coronavirus disease (COVID-19) vaccines, the Department of Science and Technology (DOST) said on Tuesday, May 25.
DOST Undersecretary Rowena Guevarra said that the three vaccine developers have already submitted their COVID-19 vaccine clinical trial applications. These are West China Hospital and Sichuan University, Shenzhen Kangtai Biological Products Co., and Eubiologics Co. Ltd.
“Evaluation of the first two new applications are ongoing, while Eubiologics Co. Ltd are still completing some requirements,” said Guevarra in an online forum hosted by the Department of Health (DOH). ....

Rowena Guevarra , Department Of Science , Department Of Health , World Health Organization , Drug Administration , Sichuan University , Shenzhen Kangtai Biological Products Co , Eubiologics Co , Manila Bulletin File , West China Hospital , Clover Biopharmaceutical , Solidarity Trials , Solidarity Vaccine Trials , Ethics Board , துறை ஆஃப் அறிவியல் , துறை ஆஃப் ஆரோக்கியம் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , ஸிச்வாந் பல்கலைக்கழகம் , ஷென்சென் காங்க்டை உயிரியல் ப்ராடக்ட்ஸ் இணை , மணிலா புல்லட்டின் கோப்பு , மேற்கு சீனா மருத்துவமனை , ஒற்றுமை சோதனைகள் , ஒற்றுமை தடுப்பூசி சோதனைகள் , நெறிமுறைகள் பலகை ,